You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD34 selected progenitors cell

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

(VIII): The Eight Study and Immunologic Response Sub-study

Recruiting
  • Vaccine Reaction
    • Chicago, Illinois
    • +1 more
    Feb 2, 2022

    Metastatic Breast Cancer Trial in Dallas (Anakinra plus Standard of Care)

    Completed
    • Metastatic Breast Cancer
    • Anakinra plus Standard of Care
    • Dallas, Texas
      Baylor University Medical Center
    Oct 7, 2021

    Head and Neck Squamous Cell Carcinoma, Cancer, Cancer of Head and Neck Trial in United States (Pembrolizumab, Radiation therapy,

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +14 more
    • Tucson, Arizona
    • +6 more
    Oct 7, 2021

    ESCORT-HU Extension: European Sickle Cell Disease Cohort -

    Recruiting
    • Sickle Cell Disease
    • Amiens, France
    • +78 more
    Mar 24, 2022

    Lymphoma, B-Cell Trial in Xi'an (Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy)

    Terminated
    • Lymphoma, B-Cell
    • Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy
    • Xi'an, Shaanxi, China
      Second Affiliated Hospital of Xi'an Jiaotong University
    Oct 28, 2021

    Chronic Hepatitis b Trial in Guangzhou (Vitamin D)

    Completed
    • Chronic Hepatitis b
    • Vitamin D
    • Guangzhou, Guangdong, China
      Department of Infectious Diseases, The Third Affliated Hospital
    Mar 2, 2023

    T Cell Lymphoma Trial in Shanghai (Chidamide combined with BEAM)

    Recruiting
    • T Cell Lymphoma
    • Chidamide combined with BEAM
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Sep 27, 2022

    Locally Advanced Pancreatic Adenocarcinoma Trial in Guangzhou (Irreversible electroporation, Gemcitabine)

    Completed
    • Locally Advanced Pancreatic Adenocarcinoma
    • Guangzhou, Guangdong, China
      Institutional Review Board of Guangzhou FUDA Cancer Hospital
    Sep 1, 2021

    Corneal Endothelial Cell Density After Transscleral ab Interno

    Completed
    Has Results
    • Glaucoma
    • Endothelial Cell Loss, Corneal
    • XEN45
    • Salzburg, Austria
      Dept. Ophthalmology and Optometry Paracelsus Medical University
    Jul 12, 2021

    Microfluidic Assessment of Clinical Outcomes in Preterm Newborns

    Active, not recruiting
    • Neonatal SEPSIS
    • Blood Collection Preterm
    • +2 more
    • Gainesville, Florida
      UF Health
    Sep 14, 2022

    PROSPECT - Profiling of Resistance Patterns & Oncogenic

    Recruiting
    • Lung Cancer
    • Cancer of Thorax
    • Group Specific Aim 1
    • +5 more
    • Houston, Texas
      M D Anderson Caner Center
    Jun 29, 2022

    Lung Cancer, Video-assisted Thoracic Surgery, EGFR Trial in Torino (Cetuximab-IRDye800)

    Not yet recruiting
    • Lung Cancer
    • +3 more
    • Torino, TO, Italy
      Azienda Ospedaliera Universitaria Città della Salute e della Sci
    Oct 23, 2023

    BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

    Withdrawn
    • BCLC Stage B Hepatocellular Carcinoma
    • +4 more
    • Atezolizumab
    • +3 more
    • (no location specified)
    Dec 12, 2022

    Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip Trial in Cleveland (HealthLoop mobile application)

    Completed
    Has Results
    • Arthroplasty, Replacement, Knee
    • Arthroplasty, Replacement, Hip
    • HealthLoop mobile application
    • Cleveland, Ohio
      Cleveland Clinic
    Oct 28, 2021

    Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Sacramento (Ibrutinib, Nivolumab)

    Completed
    Has Results
    • Metastatic Renal Cell Cancer
    • Stage IV Renal Cell Cancer
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Feb 8, 2022

    Patients With Anal Cancer Treated With Induction Chemotherapy

    Recruiting
    • Anal Cancer
    • +4 more
      • Aarhus, Aarhus N, Denmark
      • +2 more
      Feb 9, 2022

      Breast Tumors Trial in Worldwide (Herceptin)

      Completed
      Has Results
      • Breast Neoplasms
      • Tirana, Albania
      • +436 more
      Apr 26, 2021

      NSCLC Trial in Jacksonville (Peripherally located lung tumor, Centrally located lung tumor)

      Completed
      • Non-Small Cell Lung Cancer
      • Peripherally located lung tumor
      • Centrally located lung tumor
      • Jacksonville, Florida
        University of Florida Proton Therapy Institute
      Mar 23, 2022

      Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)

      Completed
      Has Results
      • Primary Myelofibrosis
      • +2 more
      • Rochester, Minnesota
        (unnamed)
      Aug 24, 2021

      Rabies, Communicable Disease, Virus Diseases Trial in Kunming (SYN023, HRIG, Rabies Vaccine)

      Active, not recruiting
      • Rabies
      • +5 more
      • SYN023
      • +2 more
      • Kunming, China
        Yunnan Province Center for Disease Control and Prevention (CDC)
      Sep 23, 2021

      Mycosis Fungoides, Cutaneous T Cell Lymphoma Trial (Low-dose total-skin electron-beam therapy, Phototherapy)

      Not yet recruiting
      • Mycosis Fungoides
      • Cutaneous T Cell Lymphoma
      • Low-dose total-skin electron-beam therapy
      • Phototherapy
      • (no location specified)
      Jan 24, 2022

      Pregnancy in Diabetics, Placenta, Fetal Growth Trial in Aalborg

      Enrolling by invitation
      • Pregnancy in Diabetics
      • +3 more
        • Aalborg, Denmark
          Aalborg University Hospital, Department of Obstetrics and Gyneco
        Jul 25, 2022

        NSCLC Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Docetaxel)

        Completed
        • Carcinoma, Non-Small-Cell Lung
        • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
        • Docetaxel
        • Beijing, China
        • +37 more
        Jan 9, 2023

        Hepatocellular Carcinoma, NSCLC Metastatic, Liver Metastases Trial in Toronto (Atezolizumab, Bevacizumab)

        Recruiting
        • Hepatocellular Carcinoma
        • +2 more
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Jan 8, 2023

        Lung Cancer Circulating Tumor Cells

        Not yet recruiting
        • Non Small Cell Lung Cancer
        • Sample
        • Nice, France
          CHU de Nice
        Dec 5, 2022